Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-kappa;B and AP-1 in islets, respectively

Experimental Biology and Medicine

Volumn 229, Issue 11, 2004, Pages 1177-1185

  Schott Ohly, Patricia ^a   Lgssiar, Abdelhakim ^a   Partke, Hans Joachim ^a   Hassan, Mohamed ^b   Friesen, Nadira ^a   Gleichmann, Helga ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Activator protein (AP) 1; MLD STZ diabetes; NOD mice; Nuclear factor (NF) B; Zinc sulfate

Indexed keywords

APOLIPOPROTEIN A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STREPTOZOCIN; ZINC SULFATE;

APOPTOSIS; CELL DESTRUCTION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; INFLAMMATION; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PROGENY; PROPHYLAXIS; REDUCTION; STIMULATION;

EID: 10044289331     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422901113     Document Type: Conference Paper

References (50)

1. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996.
2. Rabinovitch A, Skyler JS. Prevention of type I diabetes. Med Clin N Am 82:739-755, 1998.
3. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1995.
4. Green EA, Eynon EE, Flavell RA. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9:733-743, 1998.
5. Müller A, Schott-Ohly P, Dohle C, Gleichmann H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiol 205:35-50, 2002.
6. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 5:113-124, 1988.
7. Schulze-Osthoff K, Los M, Baeuerle PA. Redox signaling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol 50:735-741, 1995.
8. Kubisch HM, Wang J, Bray TM, Phillips JP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46:1563-1566, 1997.
9. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, Miyazaki J. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med 188:1445-1451, 1998.
10. Xu B, Moritz JT, Epstein PN. Overexpression of catalase provides partial protection to transgenic mouse beta cells. Free Radic Biol Med 27:830-837, 1999.
11. Chen H, Carlson EC, Pellet L, Moritz JT, Epstein PN. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50:2040-2046, 2001.
12. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71:169-175, 1994.
13. Healey D, Ozegbe P, Arden S, Chandler P, Hutton J, Cooke A. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985, 1995.
14. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159:4686-4692, 1997.
15. Lgssiar A, Hassan M, Schott-Ohly P, Friesen N, Nicoletti F, Gleichmann H. Interleukin-11 inhibits NF-κB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice. Exp Biol Med 299:425-436, 2004.
16. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 18:6845-6852, 1999.
17. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 16:4744-4753, 1996.
18. Mabley JG, Hasko G, Liaudet L, Soriano F, Southan GJ, Salzman AL, Szabo C. NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 173:457-464, 2002.
19. Giannoukakis N, Rudert WA, Trucco M, Robbins PD. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem 275:36509-36513, 2000.
20. Han X, Sun Y, Scott S, Bleich D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 50:1047-1055, 2001.
21. Sekine N, Ishikawa T, Okazaki T, Hayashi M, Wollheim CB, Fujita T. Synergistic activation of NF-kappab and inducible isoform of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells. J Cell Physiol 184:46-57, 2000.
22. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 50:2219-2224, 2001.
23. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A 94:10057-10062, 1997.
24. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683, 1998.
25. Manna SK, Aggarwal BB. Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates. J Immunol 162:1510-1518, 1999.
26. Chang I, Kim S, Kim JY, Cho N, Kim YH, Kim HS, Lee MK, Kim KW, Lee MS. Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes 52:1169-1175, 2003.
27. Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43:1020-1030, 2000.
28. Yang J, Cherian MG. Protective effects of metallothionein on streptozotocin-induced diabetes in rats. Life Sci 55:43-51, 1994.
29. Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood) 226:103-111, 2001.
30. Schulte im Walde S, Dohle C, Schott-Ohly P, Gleichmann H. Molecular target structures in alloxan-induced diabetes in mice. Life Sci 71:1681-1694, 2002.
31. Tobia MH, Zdanowicz MM, Wingertzahn MA, McHeffey-Atkinson B, Slonim AE, Wapnir RA. The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat. Mol Genet Metab 63:205-213, 1998.
32. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417, 1976.
33. Thornalley PJ, Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 827:36-44, 1985.
34. Kumari MV, Hiramatsu M, Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic Res 29:93-101, 1998.
35. Gille L, Schott-Ohly P, Friesen N, Schulte im Walde S, Udilova N, Nohl H, Gleichmann H. Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro. Pharmacol Toxicol 90:317-326, 2002.
36. Friesen NTE, Büchau AS, Schott-Ohly P, Lgssiar A, Gleichmann H. Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets is associated with diabetes induced with multiple low doses of streptozotocin in C57BL/6 male mice. Diabetologia 47:676-685, 2004.
37. Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown DR. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol 156:3521-3527, 1996.
38. Abdel-Mageed AB, Agrawal KC. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res 58:2335-2338, 1998.
39. Sciavolino PJ, Lee TH, Vilcek J. Overexpression of metallothionein confers resistance to the cytotoxic effect of TNF with cadmium in MCF-7 breast carcinoma cells. Lymphokine Cytokine Res 11:265-270, 1992.
40. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789, 1996.
41. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784, 1996.
42. Tsujikawa K, Suzuki N, Sagawa K, Itoh M, Sugiyama T, Kohama Y, Otaki N, Kimura M, Mimura T. Induction and subcellular localization of metallothionein in regenerating rat liver. Eur J Cell Biol 63:240-246, 1994.
43. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS. Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52:195-201, 1997.
44. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N. Regulatory role of metallothionein in NF-kappaB activation. FEBS Lett 455:55-58, 1999.
45. Huber AM, Gershoff SN. Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 103:1739-1744, 1973.
46. Andrews GK, Kage K, Palmiter-Thomas P, Sarras M-PJ. Metal ions induce expression of metallothionein in pancreatic exocrine and endocrine cells. Pancreas 5:548-554, 1990.
47. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res 8:3579-3583, 2002.
48. Kim CH, Kim JH, Lee J, Ahn YS. Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol 190:189-196, 2003.
49. Oteiza PI, Clegg MS, Keen CL. Short-term zinc deficiency affects nuclear factor-kappab nuclear binding activity in rat testes. J Nutr 131:21-26, 2001.
50. Akira S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138-146, 1999.